Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA, United States.
Center for Health Equity Education & Research (CHEER), University of California, San Diego, La Jolla, CA, United States.
Front Public Health. 2024 Jun 19;12:1414361. doi: 10.3389/fpubh.2024.1414361. eCollection 2024.
Non-Hispanic Black (NHB) Americans have a higher incidence of colorectal cancer (CRC) and worse survival than non-Hispanic white (NHW) Americans, but the relative contributions of biological versus access to care remain poorly characterized. This study used two nationwide cohorts in different healthcare contexts to study health system effects on this disparity.
We used data from the Surveillance, Epidemiology, and End Results (SEER) registry as well as the United States Veterans Health Administration (VA) to identify adults diagnosed with colorectal cancer between 2010 and 2020 who identified as non-Hispanic Black (NHB) or non-Hispanic white (NHW). Stratified survival analyses were performed using a primary endpoint of overall survival, and sensitivity analyses were performed using cancer-specific survival.
We identified 263,893 CRC patients in the SEER registry (36,662 (14%) NHB; 226,271 (86%) NHW) and 24,375 VA patients (4,860 (20%) NHB; 19,515 (80%) NHW). In the SEER registry, NHB patients had worse OS than NHW patients: median OS of 57 months (95% confidence interval (CI) 55-58) versus 72 months (95% CI 71-73) (hazard ratio (HR) 1.14, 95% CI 1.12-1.15, = 0.001). In contrast, VA NHB median OS was 65 months (95% CI 62-69) versus NHW 69 months (95% CI 97-71) (HR 1.02, 95% CI 0.98-1.07, = 0.375). There was significant interaction in the SEER registry between race and Medicare age eligibility ( < 0.001); NHB race had more effect in patients <65 years old (HR 1.44, 95% CI 1.39-1.49, p < 0.001) than in those ≥65 (HR 1.13, 95% CI 1.11-1.15, p < 0.001). In the VA, age stratification was not significant ( = 0.21).
Racial disparities in CRC survival in the general US population are significantly attenuated in Medicare-aged patients. This pattern is not present in the VA, suggesting that access to care may be an important component of racial disparities in this disease.
非西班牙裔黑人(NHB)美国人的结直肠癌(CRC)发病率和生存率均高于非西班牙裔白人(NHW)美国人,但生物学因素与获得医疗保健机会对这一差异的相对贡献仍未得到充分描述。本研究使用两个不同医疗保健背景下的全国性队列来研究卫生系统对这一差异的影响。
我们使用来自监测、流行病学和最终结果(SEER)登记处以及美国退伍军人健康管理局(VA)的数据,确定了 2010 年至 2020 年间被诊断为结直肠癌的成年人,他们自认为是非西班牙裔黑人(NHB)或非西班牙裔白人(NHW)。使用总生存作为主要终点进行分层生存分析,并使用癌症特异性生存进行敏感性分析。
我们在 SEER 登记处确定了 263893 例 CRC 患者(36662(14%)NHB;226271(86%)NHW)和 24375 例 VA 患者(4860(20%)NHB;19515(80%)NHW)。在 SEER 登记处,NHB 患者的 OS 比 NHW 患者差:中位 OS 为 57 个月(95%CI 55-58)与 72 个月(95%CI 71-73)(风险比(HR)1.14,95%CI 1.12-1.15, = 0.001)。相比之下,VA NHB 的中位 OS 为 65 个月(95%CI 62-69)与 NHW 为 69 个月(95%CI 97-71)(HR 1.02,95%CI 0.98-1.07, = 0.375)。SEER 登记处种族与医疗保险年龄资格之间存在显著的交互作用( < 0.001);在<65 岁的患者中,NHB 种族的影响更大(HR 1.44,95%CI 1.39-1.49,p < 0.001),而在≥65 岁的患者中则较小(HR 1.13,95%CI 1.11-1.15,p < 0.001)。在 VA 中,年龄分层并不显著( = 0.21)。
在美国普通人群中,CRC 生存的种族差异在 Medicare 年龄段患者中明显减弱。VA 中不存在这种模式,这表明获得医疗保健可能是该疾病中种族差异的一个重要组成部分。